CompletedPhase 4NCT02034799

Phase IV Bioseal Study in Brain Tumor Surgery

Studying Meningioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ethicon, Inc.
Principal Investigator
Richard Kocharian, MD, PhD, MD, PHD
Ethicon, Inc.
Intervention
Bioseal Fibrin Sealant(biological)
Enrollment
256 enrolled
Eligibility
18-75 years · All sexes
Timeline
20132014

Study locations (7)

Collaborators

Guangzhou Bioseal Biotechnology Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02034799 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma

← Back to all trials